一分钟看懂
这是一项关于Advanced Lung Neuroendocrine Tumor的II 期研究，登记的药物或干预包括Biospecimen Collection；Computed Tomography；Everolimus；Fludeoxyglucose F-18；Lutetium Lu 177 Dotatate；Magnetic Resonance Imaging；Positron Emis，当前状态为招募中。登记地点显示中国Birmingham、Beverly Hills、Loma Linda、Los Angeles等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Biospecimen Collection；Computed Tomography；Everolimus；Fludeoxyglucose F-18；Lutetium Lu 177 Dotatate；Magnetic Resonance Imaging；Positron Emission Tomography；Single Photon Emission Computed Tomography；Survey Administration · II 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- University of Alabama at Birmingham Cancer Center · Birmingham
- Tower Cancer Research Foundation · Beverly Hills
- Loma Linda University Medical Center · Loma Linda
- Cedars-Sinai Medical Center · Los Angeles
- UCSF Medical Center-Mission Bay · San Francisco
- Torrance Memorial Physician Network - Cancer Care · Torrance
- MedStar Georgetown University Hospital · Washington D.C.
- UM Sylvester Comprehensive Cancer Center at Aventura · Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables · Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach · Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center · Miami
- UM Sylvester Comprehensive Cancer Center at Plantation · Plantation
- University of Chicago Comprehensive Cancer Center · Chicago
- UC Comprehensive Cancer Center at Silver Cross · New Lenox
- University of Chicago Medicine-Orland Park · Orland Park
- UI Health Care Mission Cancer and Blood - Ankeny Clinic · Ankeny
- Iowa Methodist Medical Center · Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic · Des Moines
- Dana-Farber Cancer Institute · Boston
- Mayo Clinic in Rochester · Rochester
- Missouri Baptist Medical Center · St Louis
- Duke University Medical Center · Durham
- Case Western Reserve University · Cleveland
- Ohio State University Comprehensive Cancer Center · Columbus
- Fox Chase Cancer Center · Philadelphia
- Temple University Hospital · Philadelphia
- UPMC Hillman Cancer Center · Pittsburgh
- Vanderbilt University/Ingram Cancer Center · Nashville
- Huntsman Cancer Institute/University of Utah · Salt Lake City
公开的入选条件
- * PRE-REGISTRATION: Pathologic Documentation: Well- or moderately-differentiated neuroendocrine tumor(s) of bronchial origin (i.e. carcinoid) as assessed by local pathology
- The pathology report must state ONE of the following:
- Well- or moderately-differentiated neuroendocrine tumor,
- Low- or intermediate-grade neuroendocrine tumor, or
- Carcinoid tumor (including typical or atypical carcinoid tumors)
- * PRE-REGISTRATION: Documentation of histology from a primary or metastatic site is allowed
- * PRE-REGISTRATION: Functional (evidence of peptide hormones and/or bioactive substances associated with a clinical hormone syndrome such as carcinoid syndrome or Cushing's syndrome) or nonfunctional tumors are allowed
- * PRE-REGISTRATION: Patients with poorly-differentiated or high-grade neuroendocrine carcinoma (i.e. large cell neuroendocrine carcinoma of lung, small cell lung cancer) or mixed tumors (i.e. adenocarcinoid tumor) are not eligible
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT04665739；登记信息更新于 2026-09-17。